Willoughby Scott B. has filed 25 insider transactions across 1 company since January 2024.
Most recent transaction: a grant/award of 800000 shares of SANGAMO THERAPEUTICS, INC ($SGMO) on April 01, 2026.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| April 1, 2026 | SANGAMO THERAPEUTICS, INC | $SGMO | Willoughby Scott B. | SVP, CHIEF LEGAL OFFICER, SECY | A | Stock Option (Right to Buy) | 800000 | $0.00 | 800,000.0000 | 336,494,489 | 9999.99% | 0.24% |
| Feb. 25, 2026 | SANGAMO THERAPEUTICS, INC | $SGMO | Willoughby Scott B. | SVP, CHIEF LEGAL OFFICER, SECY | F | Common Stock | 12354 | $0.47 | 651,406.0000 | 336,494,489 | 1.86% | 0.00% |
| Feb. 24, 2026 | SANGAMO THERAPEUTICS, INC | $SGMO | Willoughby Scott B. | SVP, CHIEF LEGAL OFFICER, SECY | F | Common Stock | 1650 | $0.47 | 663,760.0000 | 336,494,489 | 0.25% | 0.00% |
| Jan. 22, 2026 | SANGAMO THERAPEUTICS, INC | $SGMO | Willoughby Scott B. | SVP, CHIEF LEGAL OFFICER, SECY | F | Common Stock | 36676 | $0.40 | 665,410.0000 | 336,494,489 | 5.22% | 0.01% |
| Nov. 24, 2025 | SANGAMO THERAPEUTICS, INC | $SGMO | Willoughby Scott B. | SVP, CHIEF LEGAL OFFICER, SECY | F | Common Stock | 2035 | $0.42 | 702,086.0000 | 336,494,489 | 0.29% | 0.00% |
| Oct. 22, 2025 | SANGAMO THERAPEUTICS, INC | $SGMO | Willoughby Scott B. | SVP, CHIEF LEGAL OFFICER, SECY | F | Common Stock | 44122 | $0.66 | 704,121.0000 | 224,710,019 | 5.90% | 0.02% |
| Aug. 24, 2025 | SANGAMO THERAPEUTICS, INC | $SGMO | Willoughby Scott B. | SVP, CHIEF LEGAL OFFICER, SECY | F | Common Stock | 1434 | $0.59 | 748,243.0000 | 224,710,019 | 0.19% | 0.00% |
| July 22, 2025 | SANGAMO THERAPEUTICS, INC | $SGMO | Willoughby Scott B. | SVP, CHIEF LEGAL OFFICER, SECY | F | Common Stock | 31866 | $0.48 | 749,677.0000 | 224,710,019 | 4.08% | 0.01% |
| May 24, 2025 | SANGAMO THERAPEUTICS, INC | $SGMO | Willoughby Scott B. | SVP, CHIEF LEGAL OFFICER, SECY | F | Common Stock | 1433 | $0.47 | 781,543.0000 | 224,710,019 | 0.18% | 0.00% |
| April 22, 2025 | SANGAMO THERAPEUTICS, INC | $SGMO | Willoughby Scott B. | SVP, GEN. COUNSEL & SECRETARY | F | Common Stock | 31866 | $0.78 | 782,976.0000 | 224,710,019 | 3.91% | 0.01% |
| Feb. 25, 2025 | SANGAMO THERAPEUTICS, INC | $SGMO | Willoughby Scott B. | SVP, GEN. COUNSEL & SECRETARY | A | Stock Option (Right to Buy) | 560000 | $0.00 | 560,000.0000 | 0 | 9999.99% | 0.00% |
| Feb. 24, 2025 | SANGAMO THERAPEUTICS, INC | $SGMO | Willoughby Scott B. | SVP, GEN. COUNSEL & SECRETARY | F | Common Stock | 1434 | $1.00 | 696,217.0000 | 0 | 0.21% | 0.00% |
| Feb. 25, 2025 | SANGAMO THERAPEUTICS, INC | $SGMO | Willoughby Scott B. | SVP, GEN. COUNSEL & SECRETARY | F | Common Stock | 1375 | $0.96 | 694,842.0000 | 0 | 0.20% | 0.00% |
| Feb. 25, 2025 | SANGAMO THERAPEUTICS, INC | $SGMO | Willoughby Scott B. | SVP, GEN. COUNSEL & SECRETARY | A | Common Stock | 120000 | $0.00 | 814,842.0000 | 0 | 17.27% | 0.00% |
| Jan. 22, 2025 | SANGAMO THERAPEUTICS, INC | $SGMO | Willoughby Scott B. | SVP, GEN. COUNSEL & SECRETARY | F | Common Stock | 129549 | $1.15 | 697,651.0000 | 0 | 15.66% | 0.00% |
| Nov. 24, 2024 | SANGAMO THERAPEUTICS, INC | $SGMO | Willoughby Scott B. | SVP, GEN. COUNSEL & SECRETARY | F | Common Stock | 1430 | $1.88 | 828,571.0000 | 0 | 0.17% | 0.00% |
| Nov. 25, 2024 | SANGAMO THERAPEUTICS, INC | $SGMO | Willoughby Scott B. | SVP, GEN. COUNSEL & SECRETARY | F | Common Stock | 1371 | $1.94 | 827,200.0000 | 0 | 0.17% | 0.00% |
| Aug. 24, 2024 | SANGAMO THERAPEUTICS, INC | $SGMO | Willoughby Scott B. | SVP, GEN. COUNSEL & SECRETARY | F | Common Stock | 1430 | $0.86 | 831,372.0000 | 0 | 0.17% | 0.00% |
| Aug. 25, 2024 | SANGAMO THERAPEUTICS, INC | $SGMO | Willoughby Scott B. | SVP, GEN. COUNSEL & SECRETARY | F | Common Stock | 1371 | $0.86 | 830,001.0000 | 0 | 0.16% | 0.00% |
| Aug. 13, 2024 | SANGAMO THERAPEUTICS, INC | $SGMO | Willoughby Scott B. | SVP, GEN. COUNSEL & SECRETARY | F | Common Stock | 892 | $0.98 | 832,802.0000 | 0 | 0.11% | 0.00% |
| May 24, 2024 | SANGAMO THERAPEUTICS, INC | $SGMO | Willoughby Scott B. | SVP, GEN. COUNSEL & SECRETARY | F | Common Stock | 1400 | $0.60 | 835,030.0000 | 0 | 0.17% | 0.00% |
| May 25, 2024 | SANGAMO THERAPEUTICS, INC | $SGMO | Willoughby Scott B. | SVP, GEN. COUNSEL & SECRETARY | F | Common Stock | 1336 | $0.60 | 833,694.0000 | 0 | 0.16% | 0.00% |
| Feb. 24, 2024 | SANGAMO THERAPEUTICS, INC | $SGMO | Willoughby Scott B. | SVP, GEN. COUNSEL & SECRETARY | F | Common Stock | 4379 | $1.13 | 839,883.0000 | 0 | 0.52% | 0.00% |
| Feb. 25, 2024 | SANGAMO THERAPEUTICS, INC | $SGMO | Willoughby Scott B. | SVP, GEN. COUNSEL & SECRETARY | F | Common Stock | 3453 | $1.13 | 836,430.0000 | 0 | 0.41% | 0.00% |
| Jan. 22, 2024 | SANGAMO THERAPEUTICS, INC | $SGMO | Willoughby Scott B. | SVP, GEN. COUNSEL & SECRETARY | A | Common Stock | 712500 | $0.00 | 844,262.0000 | 0 | 540.75% | 0.00% |